CURX Curaxis Pharmaceuticals…Great Story, Successful clinical trials, new management, could be a buyout or Pharma success. Low priced stock, but all the principles are buyingCURX could be a nice long-term play, or a good trade. Alzheimers drug research, speculative but an inexpensive stock. Pharma company stocks that get good, get really good. Vermillion went from penny stock to $30.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.